| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,424 |
1,274 |
$315K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
131 |
120 |
$40K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
727 |
612 |
$32K |
| 71045 |
Radiologic examination, chest; single view |
799 |
705 |
$21K |
| 80053 |
Comprehensive metabolic panel |
1,771 |
1,445 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,994 |
1,553 |
$13K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
498 |
459 |
$12K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
148 |
139 |
$8K |
| 84484 |
|
615 |
475 |
$7K |
| 83880 |
|
42 |
38 |
$2K |
| 81001 |
|
629 |
572 |
$2K |
| 83690 |
|
318 |
271 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
26 |
25 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
28 |
25 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
26 |
25 |
$1K |
| 84703 |
|
72 |
65 |
$750.11 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
57 |
55 |
$730.38 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
26 |
25 |
$500.36 |
| 36415 |
Collection of venous blood by venipuncture |
1,962 |
1,679 |
$471.87 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12 |
12 |
$256.80 |
| 83735 |
|
58 |
51 |
$244.27 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
44 |
41 |
$211.67 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
306 |
255 |
$165.34 |
| 85610 |
|
57 |
53 |
$160.20 |
| 85730 |
|
28 |
27 |
$142.14 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
93 |
55 |
$72.34 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
18 |
12 |
$69.44 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12 |
12 |
$18.59 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
544 |
357 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16 |
13 |
$0.00 |